References
- Parrish JA, Fitzpatrick TB, Shea C, Pathak MA. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol 1976;112:1531-1534 https://doi.org/10.1001/archderm.112.11.1531
- Grimes PE, Halder RM, Jones C, Chakrabarti SG, Enterline J, Minus HR, et al. Autoantibodies and their clinical significance in a black population. Arch Dermatol 1983;119:300-303 https://doi.org/10.1001/archderm.119.4.300
- Koga M. Vitiligo: a new classification and therapy. Br J Dermatol 1977;97:255-261 https://doi.org/10.1111/j.1365-2133.1977.tb15180.x
- Lerner AB. On the etiology of vitiligo and gray hair. Am J Med 1971;51:141-147 https://doi.org/10.1016/0002-9343(71)90232-4
- Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-666 https://doi.org/10.1016/S0190-9622(98)70194-X
- Grimes P. Vitiligo. An Overview of therapeutic approaches. Dermatol Clin 1993;11:325-338
- Siegel J, Eaglstein WH. High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1984;120:1157-1165 https://doi.org/10.1001/archderm.120.9.1157
- Barret JL, Lee HA. Corticosteroid pulse therapy in dermatology. Br J Dermatol 1982;107:31
- Pasricha JS, Seetharam KA, Dashore A. Evaluation of five different regimes for the treatment of vitiligo. Indian J Dermatol Venereol Leprol 1989;55:18-23
- Clayton R. A double-blind trial of 0.05% clobetasol propionate in the treatment of vitiligo. Br J Dermatol 1977;96:71-73 https://doi.org/10.1111/j.1365-2133.1977.tb05188.x
- Seiter S, Ugurel S, Tilgen W, Reinhold U. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo. Int J Dermatol 2000;39:624-627 https://doi.org/10.1046/j.1365-4362.2000.00006.x
- Kiesch N, Stene JJ, Goens J, Vanhooteghem O, Song M. Pulse steroid therapy for children's severe alopecia areata? Dermatology 1997;194:395-397 https://doi.org/10.1159/000246159
- Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fastspreading disease. Int J Dermatol 1993;32:753-757 https://doi.org/10.1111/j.1365-4362.1993.tb02754.x
- Radakovic-Fijan S, Furnsinn-Friedl AM, Honigsmann H, Tanew A. Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol 2001;44:814-817 https://doi.org/10.1067/mjd.2001.113475
- Wolverton SE. Glucocorticoid, In: Wolverton SE, Wilkin JK, editors. Systemic drug for skin disease. 1st ed. Philadelphia: WB Saunders, 1991:86-124
- Kim YS, Shur KB, Lee JH, Park JK. Response of PUVA therapy in vitiligo patients. Korean J Dermatol 1999;37:1752-1759
- Park YK, Park HY. Treatment of vitiligo with oral methoxsalen and UVA. Korean J Dermatol 1985;23:643-660
- Handa S, Pandhi R, Kaur I. Vitiligo: A retrospecitve comparative analysis of treatment modalities in 500 patients. J Dermatol 2001;28:461-466 https://doi.org/10.1111/j.1346-8138.2001.tb00012.x
- Park JH, Kim HJ, Lee MH. Efficacy of narrow-band UVB phototherapy in vitiligo patients. Korean J Dermatol 2003;41:1022-1027
- Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH. Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 1998;39:597-602 https://doi.org/10.1016/S0190-9622(98)70009-X